AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Oct 17, 2018

SEC Form 4/A — Form 4/A

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-07-02

Reporting Person: Baird William D III (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-02	Common Stock	M	10000	$2.45	Acquired	127622	Direct
2018-07-02	Common Stock	S	10000	$15.6292	Disposed	117622	Direct

Footnotes

F1: This Form 4 amendment corrects the reporting person's amount of securities beneficially owned following the reported transaction.

F2: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

F3: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.45 to $15.91. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.